MATERIALS AND METHODS
The data sources for this study have been described in detail previously (Johansen et al, 1996) . The current study extended the follow-up for cancer through 1993 and used a broader cohort selection criterion to include gallstone patients with concomitant conditions such as bile duct stones, inflammation and perforation within the biliary tract. The National Registry of Patients maintains records of over 99% of hospital discharges for somatic diseases in Denmark (Danish National Board of Health, 1981) . Each discharge record contained a personal identification number unique to each Danish citizen, date of discharge and up to 20 diagnoses, classified according to a Danish modification of the International Classification of Diseases, eighth revision . In addition, surgical procedures were recorded and classified according to the Danish Classification of Surgical Procedures and Therapies (Danish National Board of Health, 1986) .
All discharge records with a diagnosis of cholelithiasis (ICD-8 574.00-09) from 1977 to 1989 were extracted. For patients with multiple hospital discharges for gallstones, the date of the first hospital discharge was used as the date of entry into the cohort. Using the personal identification number, linkage was made to the Danish National Board of Health to obtain information on vital status and to the Danish Cancer Registry for information on incident cancers (Storm et al, 1992) . Of 64 420 patients initially identified from the Danish National Registry of Patients, 4244 (6.6%) were excluded because of death during the first year of follow-up, leaving 60 176 patients for the study. Patients were followed up for cancer occurrence until the date of death or the end of 1993, whichever came first. To minimize selection bias, cancer diagnoses and personÐyears accumulated during the first year of follow-up were excluded from analysis.
Among the cohort members, 42 461 (65.9%) were treated by cholecystectomy, 96% of operations being performed within 6 months of the index hospitalization for gallstones. Analyses were conducted for the entire cohort, and with stratification by cholecystectomy status. PersonÐyears and cancer incidence before cholecystectomy were classified with the non-cholecystectomy stratum, and personÐyears for the cholecystectomy stratum were accumulated following the surgery. Within the cholecystectomy subcohort, further analyses were conducted to examine whether risks varied with or without accompanying bile duct surgery, which may affect risk by associated bile duct stones or subsequent alterations in bile flow. Furthermore, to assess whether risks were confounded by other conditions associated with gallstone disease and the cancer outcomes of interest, additional analyses were conducted with stratification by obesity and by selected hepatic diseases, including hepatitis, cirrhosis, haemochromatosis and alcoholism, as discharge diagnoses during any hospital visit.
The expected numbers of cancers were calculated by multiplying the number of personÐyears in the cohort by the national cancer incidence rates for each stratum by sex and age in 5-year groups. Standardized incidence ratios (SIRs), the ratio of observed to expected cancer cases and corresponding 95% confidence intervals (CIs) were computed for 1Ð4 and ³5 years intervals following hospital discharge for gallstones. Tests of significance for the SIR were based on the assumption that the observed number of a specific cancer followed a Poisson distribution, with a mean value equal to the expected number derived from the general population (Bailar and Ederer, 1964) . In addition, to assess the potential for surveillance bias, SIRs were computed after excluding patients whose cancer of interest was diagnosed incidentally during autopsy from both the observed number as well as from the population rates used in calculating the expected number. Biliary tract cancer risk was evaluated by anatomical subsite, including the gallbladder, extrahepatic bile ducts and ampulla of Vater. For comparison, SIRs were computed for cancers arising from adjacent sites, i.e. the liver and pancreas. a Person-years (2308) and cancers (7) for these patients prior to their cholecystectomy were allocated to the never/before cholecystectomy stratum. b Adjusted for age and gender. a Adjusted for age and gender. b Person-years for this stratum were accumulated after the cholecystectomy which might be subsequent to cohort entry.
RESULTS
A total of 471 450 personÐyears of follow-up were accrued, with 109 803 personÐyears allocated in the non-cholecystectomy stratum and 361 648 in the cholecystectomy stratum (Table 1) . The non-cholecystectomy group was much older at cohort entry than the cholecystectomy group (mean age 70 vs 56 years). There were generally more women than men, with a female-to-male ratio of 2.1 in the non-cholecystectomy group and 2.8 in the cholecystectomy group. Among those without cholecystectomy, the mean duration of follow-up was 6.1 years after cohort entry versus 9.2 years following cholecystectomy. Overall, the risks for liver and extrahepatic bile duct tumours tended to be higher in the non-cholecystectomy than the cholecystectomy group, although these differences were not statistically significant (Table 1) . Risk estimates for the non-cholecystectomy stratum were essentially unaltered when personÐyears (2308) and cancers (7) for patients who subsequently had cholecystectomy were excluded (data not shown).
In the non-cholecystectomy group, the risks for cancers of liver and gallbladder remained significantly elevated at 5 or more years of follow-up (SIR = 2.0 and 2.7 respectively), as shown in Table 2 . In contrast, the risks for cancers of extrahepatic bile duct, ampulla of Vater and pancreas declined to near unity at 5 or more years of follow-up.
On the other hand, in the cholecystectomy group, the risks for cancers of liver and extrahepatic bile duct cancers dropped to 1.1 and 0.7, respectively, at 5 or more years of follow-up. In contrast, the risks for cancers of ampulla of Vater and pancreas remained elevated (SIR = 2.0 and 1.3 respectively), with the excess of pancreas cancer being statistically significant throughout follow-up.
In the cholecystectomy stratum, the risks for cancers of extrahepatic bile duct and ampulla of Vater were similar among patients who had cholecystectomy only and those who had bile duct surgery along with cholecystectomy (Table 3) . However, the risk for liver cancer was higher among patients with cholecystectomy only than among those who also had bile duct surgery, whereas the risk for pancreas cancer was higher among those with accompanying bile duct surgery than among those with cholecystectomy only.
The cancer risks (except for liver cancer) were essentially unaltered when the analyses were restricted to patients who never had a hospital discharge diagnosis of obesity or hepatic diseases (Table 3) . For liver cancer, however, the risks were near unity among those without a history of hepatic conditions and were increased substantially among those with such a history. The results were similar regardless of cholecystectomy status (data not shown). The numbers of biliary tract cancers among patients with a diagnosis of obesity or hepatic conditions were too small for meaningful analysis, whereas the risk for pancreas cancer was increased twofold.
Exclusion of cancer cases diagnosed incidentally during autopsy did not appreciably alter the associations seen for cancers of gallbladder, extrahepatic bile duct, ampulla of Vater and pancreas (Table 3 ). The risk of liver cancer, however, was reduced to 1.2 among those without cholecystectomy, but remained slightly elevated at 1.4 among those treated with cholecystectomy.
DISCUSSION
Our findings among gallstone patients without cholecystectomy are consistent with previous reports indicating that gallstone disease predisposes to biliary tract cancers, particularly gallbladder cancer (Lowenfels et al, 1985; Maringhini et al, 1987; Yen et al, 1987; Chow et al, 1994; Fraumeni et al, 1996) . Although the risk for gallbladder cancer remained elevated at 5 or more years after hospitalization for gallstone disease, the risks for cancers of extrahepatic bile duct and ampulla of Vater dropped to near unity, suggesting that residual selection bias associated with the detection of existing tumours during the early years of follow-up contributed to the overall excess of bile duct and ampullary tumours. The risk for extrahepatic bile duct cancers tended to be lower among patients with cholecystectomy than among those not treated surgically, with risk dropping to below unity at 5 or more years of follow-up. This finding is consistent with an earlier Swedish cohort study of cholecystectomy patients indicating a significantly lowered risk of extrahepatic bile duct cancer after long-term follow-up (Ekbom et al, 1993) .
Also consistent with the recent Swedish study (Ekbom et al, 1996) , patients in our cholecystectomy group had significantly elevated risks for cancers of ampulla of Vater and pancreas that persisted after 5 or more years of follow-up, although the longterm excess of pancreatic cancer was small. While selection bias, small numbers and chance variation may partly explain this finding, it seems plausible that cholecystectomy rather than gallstone formation is the more important risk factor for cancers of ampulla of Vater and perhaps pancreas. In laboratory animals, cholecystectomy has been shown to stimulate pancreatic hypertrophy and hyperplasia (Rosenberg et al, 1984) and predispose to benign and malignant tumours of the pancreas (Ura et al, 1986; Watanapa and Williamson, 1993) . Although the mechanism of action is unclear, it has been suggested that cholecystectomy increases circulating levels of cholecystokininÐpancreozymin, a gastrointestinal hormone with trophic effects on the pancreas (Watanapa and Williamson, 1993; Anderson et al, 1996) . The elevated risk of liver cancer among patients without cholecystectomy may be explained, in part, by increased surveillance, as exclusion of cases diagnosed incidentally at autopsy reduced the risk to near unity. In addition, the risk of liver cancer was reduced to unity among cohort members who were not previously hospitalized for hepatic diseases, suggesting that gallstone disease without hepatic complications is not an important risk factor for liver cancer. As gallstones and other extrahepatic diseases may increase inflammatory mediators such as cytokine expression in the liver (Fukuma et al, 1996) , however, further assessment of the risk of liver cancer among gallstone patients may be warranted.
While obesity is a well-established risk factor for gallbladder cancer (Fraumeni et al, 1996) and may also be linked to cancers of liver and pancreas (Moller et al, 1994) , exclusion of patients who were never hospitalized with obesity did not affect the risk estimates. These findings suggest that obesity is unlikely to account for the entire excesses of these tumours in our cohort.
A few methodological issues should be considered in interpreting findings from our registry-based cohort study. Reporting of cancers diagnosed among Danish residents and follow-up of cohort members for death and emigration are nearly complete (Storm et al, 1992) , thus minimizing selection bias. In Denmark, nearly all diagnoses of gallstones are verified by radiography or ultrasonography, so that misclassification of non-cases into the cohort is unlikely. However, a substantial proportion of individuals with gallstones may remain undiagnosed. To the extent that patients hospitalized for gallstones may have risk patterns that differ from those of individuals with ÔsilentÕ stones or mild symptoms not requiring hospitalization, our findings are not generalizable to non-hospitalized patients. Furthermore, if a substantial proportion of the general population has undiagnosed gallstones which predispose to cancer, then risks in our cohort may be underestimated. On the other hand, it is possible that cholecystectomies were sometimes carried out on account of the early symptoms of biliary tract cancers which had been erroneously attributed to the gallstones that were present. This may have contributed to the excess of certain biliary tract cancers, at least in the early period. To minimize bias due to diagnosis of prevalent cancers, we excluded the personÐyears and cancers occurring during the first year of follow-up. Although some of the significant results in our study might have occurred by chance because of multiple comparisons, the consistency of the risk patterns within our dataset and with results of the Swedish study supports the validity of our findings.
Information on potential confounding factors such as cigarette smoking and alcohol drinking was not available for adjustment. In our cohort, however, there was no excess risk for cancers that are strongly linked to use of tobacco or alcohol, such as lung cancer (SIR = 1.0, 95% CI = 0.9Ð1.1) and cancers of the buccal cavity and pharynx (SIR = 1.1, 95% CI = 0.9Ð1.4), suggesting that these risk factors are unlikely to have influenced our findings. It should be noted that the results for patients with and without cholecystectomy may not be directly comparable, as the non-surgical patients were much older and likely to have other medical conditions that precluded surgery.
In conclusion, patients hospitalized for gallstones had an elevated risk of subsequent cancers of the liver, biliary tract and pancreas. Treatment with cholecystectomy was associated with a reduction in the long-term risk for cancers of liver and extrahepatic bile ducts, but not for cancers of ampulla of Vater and pancreas. Further research is needed to clarify the carcinogenic risks associated with gallstones and cholecystectomy and to define the mechanisms involved.
